PVG.L Regulatory News (PVG)

16 Feb 2007 09:00

Ark Therapeutics Group PLC16 February 2007 Ark Therapeutics Group plc 2007 Notification of Major Interests in Shares (1). Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii): ARK THERAPEUTICS GROUP PLC 2. Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights: ( ) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ( ) An event changing the breakdown of voting rights: ( ) Other - confirmation of holding ( X ) 3. Full name of person(s) subject to the notification obligation: AMVESCAP PLC 4. Full name of shareholder(s) (if different from 3): 5. Date of the transaction and date on which the threshold is crossed or reachedif different: Not advised 6. Date on which issuer notified: 15 February 2007 7. Threshold(s) that is/are crossed or reached: 8. Notified details: A: Voting rights attached to shares Class/type of shares (is possible using ISIN Code: Ordinary shares of 1p each GB0034251727 Situation previous to the triggering transaction: Number of shares: 14,331,051 Number of voting rights: 14,331,051 Resulting situation after the triggering transaction Number of shares: 14,331,051 Direct: Number of voting rights: Direct: Indirect: 14,331,051 % of voting rights: Direct: Indirect: 8.63% B: Financial Instruments: Resulting situation after the triggering transaction: Type of financial instrument: Expiration date: Exercise/conversion period/date: Number of voting rights that may be acquired if the instrument is exercised/ converted: % of voting rights: Total (A+B) Number of voting rights: 14,331,051 % of voting rights 8.63% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: 14. Contact name: Samantha Edwards 15. Contact telephone number: 01491 416381 16. Contact name and telephone at issuer: NICK PLUMMER Company Secretary Ark Therapeutics Group plc 020 7388 7722 16 February 2007 This information is provided by RNS The company news service from the London Stock Exchange